Joseph Jimenez, Global Quality Leader, Joins Validant Group

WASHINGTON--(BUSINESS WIRE)--The Validant Group, a leading global provider of comprehensive and innovative regulatory consulting services for the life sciences industry, today announced that Joseph Jimenez has joined the firm as Partner. Joseph is a global quality leader with a career spanning nearly 30-years in the pharmaceutical, medical device, human tissue, and consumer goods organizations. His experience enhances the Validant Group’s quality assurance and strategic regulatory compliance capabilities.

Joseph’s extensive experience includes leadership roles at Teva Pharmaceuticals where he served as Vice President, PGT Quality. In this role, Joseph provided leadership and strategic guidance to the $1.6 billion global joint venture between Proctor & Gamble and Teva. During his 10-year tenure at Teva Pharmaceuticals, Joseph was responsible for improving compliance profiles of manufacturing facilities and leading remediation of critical and major compliance observations to improve the company’s regulatory profile.

Prior to joining Teva Pharmaceuticals, Joseph’s experience included more than seven years with IVAX Pharmaceuticals in roles overseeing quality control and analytical services activities. Most recently, Joseph established the Arches Consulting firm where he worked with foreign and domestic clients in the pharmaceutical industry to develop quality assurance and regulatory strategies for compliance with regulations.

At the Validant Group, Joseph will provide strategic guidance and support to pharmaceutical and medical device companies in areas, including: strengthening corporate quality systems; developing compliance strategies; assisting industry clients in developing and communicating corrective action plans that meet FDA expectations and that achieve and sustain compliance; conducting audits and mock inspections; ensuring inspection readiness; and providing training, coaching, and mentoring.

“Joe has been recognized for building high-performance teams, developing talent, and providing astute cultural awareness. He has established an exemplary track record of guiding pragmatic change to organizational compliance culture to bring the best out of players. His wealth of experience and deep industry knowledge will further enhance our ability to deliver value to our clients,” said Brian Burns, President, Validant.

The Validant Group is a global, full-service life science consulting company focused on managing and resolving complex regulatory issues. The Validant Group’s growth strategy is supported by GHO Capital Partners LLP, a leading specialist healthcare investment advisor based in London. GHO applies global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value. For further information, please visit www.ghocapital.com.

Taryn Walpole
twalpole@validant.com